Skip to content

Development of Magnetic Resonance (MR) Simulation for Treatment Planning

Development of MR Simulation for Treatment Planning

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00314496
Enrollment
10
Registered
2006-04-14
Start date
2005-09-30
Completion date
2009-11-30
Last updated
2016-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Retrospectively have access to MR images of patients to develop software that: 1. segment images 2. convert MR values to electron density and then 3. entered into a dose calculation system The project involves software development of data that is already available. No intervention is made at this point.

Interventions

None listed

Sponsors

Cross Cancer Institute
CollaboratorOTHER
AHS Cancer Control Alberta
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject 18 years of age and older

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026